SKI Market

Indian Indices

Sensex

83,576.24 -604.72
( -0.72%)

Global Indices

Nasdaq

49,520.87 233.75
(0.47%)

Dow Jones

6,986.78 44.32
(0.64%)

Hang Seng

51,918.01 800.75
(1.57%)

Nikkei 225

10,123.15 78.46
(0.78%)

Forex

USD-INR

89.91 -0.02
(-0.02%)

EUR-INR

104.90 -0.20
(-0.19%)

GBP-INR

120.86 -0.43
(-0.35%)

JPY-INR

0.57 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Infollion Research Services Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

78698

INE0NNZ01013

55.6873548

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INFOLLION

33.78

369.79

EPS(TTM)

Face Value()

Div & Yield %

11.29

Back

Concord Drugs consolidated net profit rises 375.00% in the September 2025 quarter

Nov 14,2025

Net profit of Concord Drugs rose 375.00% to Rs 0.19 crore in the quarter ended September 2025 as against Rs 0.04 crore during the previous quarter ended September 2024. Sales declined 16.83% to Rs 10.28 crore in the quarter ended September 2025 as against Rs 12.36 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	10.28	12.36	-17
OPM %	10.70	7.12	-
PBDT	0.61	0.41	49
PBT	0.27	0.07	286
NP	0.19	0.04	375

83,576.24 -604.72 ( -0.72%)

49,520.87 233.75 (0.47%)

6,986.78 44.32 (0.64%)

51,918.01 800.75 (1.57%)

10,123.15 78.46 (0.78%)

89.91 -0.02 (-0.02%)

104.90 -0.20 (-0.19%)

120.86 -0.43 (-0.35%)

0.57 0.00 (-0.15%)